Efficacy of thalidomide plus MP regimen for treatment of the patients with multiple myeloma
- Author:
- No author available
- Journal Title:
- JOURNAL OF LEUKEMIA & LYMPHOMA
- Issue:
- 2
- DOI:
- 10.3760/cma.j.issn.1009-9921.2011.02.007
- Key Word:
- 多发性骨髓瘤;抗肿瘤联合化疗方案;沙利度胺;Multiple myeloma;Antineoplastic combined chemotherapy protocds;Thalidomide
Abstract： Objective To compare the efficacy and toxicity of melphalan + prednisone + thalidomide regimen (MPT) and melphalan + prednisone regimen (MP) in the treatment of multiple myeloma (MM).was given 100-200 mg/d everyday. 21 cases in MP group, the dose of melphalan and prednisone were the same as that in MPT group. The efficacy was evaluated after 6 cycles of treatment. Results The overall response rate (ORR) of MPT group and MP group were 65.4 % and 42.9 %, respectively (P＞O.05). The median response time in MPT group versus MP group was 2 months versus 3 months. Compared with the MP group. the increase of hemoglobin and albumin concentration in the MPT group is significantly higher (P＜ 0.05).The incidence of adverse effects of MPT group was higher than that of MP group (P ＜0.05), but the percentage of grade 3 and grade 4 toxicity was no different. The median PFS in MPT group was 11 months, 2-year PFS was 66.18 %. Conclusion Compared with MP, MPT could achieve higher response rate, improve the life quality and prolong the survival time of MM patients with better tolerance.
- [1]万继萍,陈建斌.沙利度胺联合MP化疗方案治疗多发性骨髓瘤的疗效评价[J].2007,(17).
- [2]袁振刚,侯健,王东星,等.沙利度胺联合地塞米松诱导治疗初诊多发性骨髓瘤[J].2007,(12).
- [3]曲东霞.沙利度胺联合小剂量MP方案化疗治疗老年多发性骨髓瘤的临床观察[J].2007,(3).
- [4]申曼,王晶,杨光忠,等.雷利度胺为主方案治疗多发性骨髓瘤25例疗效分析[J].2010,(7).
- [5]路平,路蓉,王永志,等.沙利度胺联合MP方案治疗多发性骨髓瘤48例[J].2006,(10).
- [6]石昊天,周帆,侯健,等.不同剂量地塞米松联合沙利度胺治疗多发性骨髓瘤[J].2010,(7).
- [7]Durie BG,Harousseau JL,Miguel JS,etc.International uniform response criteria for multiple myeloma.[J].2006,20(9).
- [8]邓家栋主编.临床血液学[M].1985.
- [9]张之南.血液病诊断及疗效标准[M].1998.
- [10]Ciccone G,Musto P,Boccadoro M,etc.Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial.[J].2006,367(9513).
- [11]Attal, Michel,Harousseau, Jean-Luc,Stoppa, Anne-Marie,etc.A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma.[J].1996,335(2).
- [12]Drayson MT,Bell SE,Hawkins K,etc.High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.[J].2003,348(19).